WHO prequalifies meningitis conjugate vaccine
European Pharmaceutical Review
JULY 12, 2023
This news builds on the success of the MenAfriVac ® vaccine, which eliminated serogroup A meningococcal meningitis outbreaks from the meningitis belt after being introduced in 2010. “[We] They do not promote herd immunity and are not generally effective in infants and children younger than two years old.
Let's personalize your content